Molecular structural basis for polymorphism in Alzheimer's β-amyloid fibrils
By A. Paravastu, Richard Leapman, Wai-Ming Yau, R. Tycko. Proceedings of the National Academy of Sciences of the United States of America, 2008
1,109 citations recorded by the source corpus.
Subfields: Biomaterials, Molecular Biology, Physiology
View Paper: https://www.semanticscholar.org/paper/b273dfd43b2082a4da4eec8f01f0eafda29104ce
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomaterials
In Molecular Biology
- Fabrizio Chiti
- Christopher M. Dobson
- Steven O. Smith
- Takeshi Sato
- J. Elliott
- S. Aimoto
- S. Ahuja
- Judianne Davis
In Physiology
- Christopher M. Dobson
- Fabrizio Chiti
- Steven O. Smith
- Takeshi Sato
- J. Elliott
- S. Aimoto
- S. Ahuja
- Judianne Davis
Citations in the corpus
- Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade. (2017, methodology): “Such structure has generally been shown to involve both antiparallel (174, 181) and parallel and out-of-register strands (176), compared with the structure of the fibrils in which the β-strands are arranged in a parallel and in-register manner (72, 82, 83, 85, 122).”
- Structural conversion of neurotoxic amyloid-β(1–42) oligomers to fibrils (2010, positive): “The side-chain packing registry within the β -turn- β motif of A β 42 fibrils is similar to that observed in A β 40 fibrils by Tycko and co-workers 19 , 20 (Fig.”